| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
1,297,254
|
1,312,699
|
1,632,530
|
1,285,170
| | Cost of Revenue | 895,152 | 1,046,372 | 968,194 | 938,859 | | |
Gross Profit
|
402,102
|
266,327
|
664,336
|
346,311
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 123,086 | 117,439 | 103,590 | 115,077 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
268,830
|
133,321
|
546,505
|
226,781
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 2,043 | (3,340) | (2,016) | 7,770 |
|
Earnings Before Interest And Taxes | 281,059 | 145,548 | 558,730 | 239,004 |
|
Interest Expense | 12,229 | 12,227 | 12,225 | 12,223 |
|
Income Before Tax | 268,830 | 133,321 | 546,505 | 226,781 |
|
Income Tax Expense | 41,675 | 22,826 | 64,148 | 50,136 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 227,155 | 110,495 | 482,357 | 176,645 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
234,370
|
111,520
|
486,707
|
176,146
| | Preferred Stock And Other Adjustments | (23,834) | (15,406) | (15,405) | (15,406) | | |
Net Income Applicable To Common Shares
|
210,536
|
96,114
|
471,302
|
160,740
|
|
0.60(0.68%) 12:41PM EDT - Nasdaq Real Time Price